+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Beigene"

PARP Inhibitors Drug Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

PARP Inhibitors Drug Therapy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 183 Pages
  • Global
From
Cancer Immunotherapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Immunotherapy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
Blood Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Blood Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 192 Pages
  • Global
From
Oncology Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Oncology Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 187 Pages
  • Global
From
Liver Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Liver Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
Cancer Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Cancer Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 195 Pages
  • Global
From
Targeted Therapy Market - Global Forecast 2026-2032 - Product Thumbnail Image

Targeted Therapy Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 185 Pages
  • Global
From
Immune Checkpoint Inhibitors Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immune Checkpoint Inhibitors Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 197 Pages
  • Global
From
Immuno-Oncology Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immuno-Oncology Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 197 Pages
  • Global
From
Antitumor ADC Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Antitumor ADC Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 184 Pages
  • Global
From
MEK Inhibitor Market - Global Forecast 2026-2032 - Product Thumbnail Image

MEK Inhibitor Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 194 Pages
  • Global
From
From
From
From
From
Liver Cancer Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Liver Cancer Therapeutics - Global Strategic Business Report

  • Report
  • January 2026
  • 287 Pages
  • Global
From
Compounding Chemotherapy - Global Strategic Business Report - Product Thumbnail Image

Compounding Chemotherapy - Global Strategic Business Report

  • Report
  • January 2026
  • 470 Pages
  • Global
From
Targeted Cancer Therapy - Global Strategic Business Report - Product Thumbnail Image

Targeted Cancer Therapy - Global Strategic Business Report

  • Report
  • January 2026
  • 396 Pages
  • Global
From
Loading Indicator

BeiGene is a market within the context of Oncology Drugs, which are drugs used to treat cancer. These drugs are used to target and destroy cancer cells, while minimizing damage to healthy cells. BeiGene is a biopharmaceutical company that develops and commercializes innovative molecularly targeted and immuno-oncology drugs for the treatment of cancer. The company focuses on developing therapies that target cancer cells with precision and accuracy, while also providing a safe and effective treatment for patients. BeiGene's portfolio includes a range of drugs, including small molecules, antibodies, and other biologics. The company also has a pipeline of novel therapies in development. BeiGene is one of many companies in the Oncology Drugs market. Other companies include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, Novartis, Pfizer, and Roche. Show Less Read more